JPH0428244B2 - - Google Patents
Info
- Publication number
- JPH0428244B2 JPH0428244B2 JP61294588A JP29458886A JPH0428244B2 JP H0428244 B2 JPH0428244 B2 JP H0428244B2 JP 61294588 A JP61294588 A JP 61294588A JP 29458886 A JP29458886 A JP 29458886A JP H0428244 B2 JPH0428244 B2 JP H0428244B2
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic
- gel
- drug
- polymer
- viscosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940023490 ophthalmic product Drugs 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 34
- 239000003732 agents acting on the eye Substances 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 21
- 238000009472 formulation Methods 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 12
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 claims description 9
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 claims description 9
- 229960001416 pilocarpine Drugs 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 6
- YYXLGGIKSIZHSF-UHFFFAOYSA-N ethene;furan-2,5-dione Chemical compound C=C.O=C1OC(=O)C=C1 YYXLGGIKSIZHSF-UHFFFAOYSA-N 0.000 claims description 4
- 239000000499 gel Substances 0.000 description 28
- 238000000034 method Methods 0.000 description 17
- 239000003814 drug Substances 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 208000030533 eye disease Diseases 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229920006158 high molecular weight polymer Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010027646 Miosis Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 2
- 229960004484 carbachol Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003547 miosis Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229960002139 pilocarpine hydrochloride Drugs 0.000 description 2
- RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical group 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940069265 ophthalmic ointment Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87207478A | 1978-01-25 | 1978-01-25 | |
| US872074 | 1978-01-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62215518A JPS62215518A (ja) | 1987-09-22 |
| JPH0428244B2 true JPH0428244B2 (US07608600-20091027-C00054.png) | 1992-05-13 |
Family
ID=25358780
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54003844A Expired JPS6059885B2 (ja) | 1978-01-25 | 1979-01-16 | 眼科用水性ゲル製剤 |
| JP61294588A Granted JPS62215518A (ja) | 1978-01-25 | 1986-12-10 | 眼科用水性ゲル製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54003844A Expired JPS6059885B2 (ja) | 1978-01-25 | 1979-01-16 | 眼科用水性ゲル製剤 |
Country Status (7)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3066859D1 (en) | 1979-10-26 | 1984-04-12 | Smith & Nephew Ass | Autoclavable emulsions |
| GB2075837B (en) * | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
| US6255299B1 (en) | 1985-01-07 | 2001-07-03 | Leo Pharmaceutical Products Ltd. | Opthalmic gel composition and method of treating eye infections |
| GB8500310D0 (en) * | 1985-01-07 | 1985-02-13 | Leo Pharm Prod Ltd | Pharmaceutical preparation |
| US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
| US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
| US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
| JP2873530B2 (ja) * | 1991-12-13 | 1999-03-24 | 参天製薬株式会社 | ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤 |
| CN1049358C (zh) * | 1993-01-01 | 2000-02-16 | 参天制药株式会社 | 含羧酸乙烯聚合物的滴眼剂及其制造方法 |
| US5340572A (en) * | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
| AU692852B2 (en) | 1994-03-04 | 1998-06-18 | University Of Washington | Block and graft copolymers and methods relating thereto |
| US5683709A (en) * | 1994-05-05 | 1997-11-04 | Ciba Vision Corporation | Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions |
| DE19614823A1 (de) * | 1996-04-15 | 1997-10-16 | Mann Gerhard Chem Pharm Fab | Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge |
| BR0014751A (pt) | 1999-10-15 | 2002-07-02 | Leo Pharm Prod Ltd | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto |
| DE602004023516D1 (de) * | 2003-08-07 | 2009-11-19 | Allergan Inc | Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung |
| DE102010009475B4 (de) | 2010-02-26 | 2011-11-24 | F. Holzer Gmbh | Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4994818A (US07608600-20091027-C00054.png) * | 1972-12-27 | 1974-09-09 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1012060A (en) * | 1964-10-06 | 1977-06-14 | Gilman N. Cyr | Dimethyl sulfoxide gel preparations |
| DE2015300A1 (de) * | 1969-04-01 | 1970-10-29 | Syntex Corp., Panania;PM | örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung |
| DK135267A (US07608600-20091027-C00054.png) * | 1971-02-25 | |||
| DE2239206A1 (de) * | 1971-08-12 | 1973-03-15 | Hydrophilics Int Inc | Copolymer |
| US3957740A (en) * | 1972-04-24 | 1976-05-18 | Hydrophilics International, Inc. | Copolymers |
| FR2191941A1 (en) * | 1972-07-10 | 1974-02-08 | Serabonian Giacomo | Gelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt |
| DE2265164C3 (de) * | 1972-10-18 | 1985-08-22 | Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva | Verwendung von Acrylsäureamidcopolymeren zur Herstellung von Grundlagen für ophthalmologische Arzneiformen |
| LU70487A1 (US07608600-20091027-C00054.png) * | 1974-07-08 | 1976-05-31 | ||
| US4003991A (en) * | 1974-08-27 | 1977-01-18 | National Patent Development Corporation | Ophthalmic formulation |
| JPS5138412A (en) * | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
| IL50250A (en) * | 1975-08-27 | 1980-01-31 | Hydrophilics Int Inc | Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups |
| JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
-
1978
- 1978-11-23 GB GB7845835A patent/GB2013084B/en not_active Expired
- 1978-12-21 CA CA318,447A patent/CA1108053A/en not_active Expired
-
1979
- 1979-01-12 FR FR7900789A patent/FR2415459A1/fr active Granted
- 1979-01-16 JP JP54003844A patent/JPS6059885B2/ja not_active Expired
- 1979-01-23 MX MX797677U patent/MX6520E/es unknown
- 1979-01-24 CH CH71879A patent/CH640737A5/de not_active IP Right Cessation
- 1979-01-25 DE DE2902863A patent/DE2902863C2/de not_active Expired - Lifetime
-
1986
- 1986-12-10 JP JP61294588A patent/JPS62215518A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4994818A (US07608600-20091027-C00054.png) * | 1972-12-27 | 1974-09-09 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2013084B (en) | 1982-07-28 |
| JPS62215518A (ja) | 1987-09-22 |
| JPS6059885B2 (ja) | 1985-12-27 |
| MX6520E (es) | 1985-06-27 |
| CA1108053A (en) | 1981-09-01 |
| DE2902863A1 (de) | 1979-07-26 |
| DE2902863C2 (de) | 1994-02-24 |
| FR2415459B1 (US07608600-20091027-C00054.png) | 1983-03-18 |
| FR2415459A1 (fr) | 1979-08-24 |
| GB2013084A (en) | 1979-08-08 |
| CH640737A5 (de) | 1984-01-31 |
| JPS54110312A (en) | 1979-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4271143A (en) | Sustained release ophthalmic drug dosage | |
| US4407792A (en) | Sustained release ophthalmic drug dosage | |
| US5275820A (en) | Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles | |
| JPH0428244B2 (US07608600-20091027-C00054.png) | ||
| JPH07504663A (ja) | 薬剤化合物の調節的デリバリーのための組成物 | |
| US4248855A (en) | Pharmaceutical base salts | |
| US5106615A (en) | Eyedrops having non-newtonian rheological properties | |
| CA1105834A (en) | Ophthalmic preparations and process for producing the same | |
| US3843778A (en) | Antacids | |
| US3252859A (en) | Colloidal silica-oil composition and method of using same | |
| JP3181912B2 (ja) | 可逆ゲル化組成物および使用方法 | |
| JP2001509780A (ja) | 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用 | |
| US4150110A (en) | Coated granules of polyacrylic alkali metal salts and method of producing same | |
| JPH05507683A (ja) | ポリマードラッグデリバリーシステム | |
| JPH0338250B2 (US07608600-20091027-C00054.png) | ||
| CN101336887A (zh) | 结膜下给药用药物组合物 | |
| JP2000508646A (ja) | 眼における滞留時間の長い目薬組成物 | |
| JPH07508030A (ja) | カルシウムアンタゴニストと公知の抗緑内障薬との組合せを含む眼局所用組成物 | |
| JP2536806B2 (ja) | ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物 | |
| WO1994010976A1 (en) | Polyvinyl alcohol/borate ophthalmic drug delivery system | |
| JP2000516614A (ja) | 製薬適用用組成物 | |
| DE2636559C2 (de) | Stabile Zubereitung zur gleichmäßigen Freigabe einer pharmazeutischen Verbindung | |
| DE3400106A1 (de) | Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung | |
| CA2147362C (en) | Topical ophthalmic pharmaceutical vehicles | |
| US5200180A (en) | Pharmaceutical composition for the treatment of the human eye |
